GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Maternal Estradiol Levels During Pregnancy Found to Influence Fetal Brain Development Differently in Male and Female Mice

by GOAI
Share To

A recent study has identified significant effects of maternal estradiol levels on fetal brain development in mice, revealing sex-specific differences in outcomes. Researchers found that elevated levels of maternal estradiol during critical developmental periods influenced the formation and function of the fetal brain, with distinct impacts observed between male and female offspring. The findings underscore the sensitivity of the developing brain to hormonal variations during pregnancy.

The research team, led by Wang et al., focused on how excess maternal estradiol affected neural development in mice. Their work highlighted specific windows during gestation when the fetal brain is particularly responsive to hormonal changes. The study demonstrated that these hormonal fluctuations resulted in alterations to brain structure and function, which varied depending on the sex of the fetus. While further investigation is needed to fully understand these mechanisms, this research provides new insights into how maternal hormone levels may play a role in shaping early brain development.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top